These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33617094)

  • 1. MTOR promotes basal cell carcinoma growth through atypical PKC.
    Chow RY; Levee TM; Kaur G; Cedeno DP; Doan LT; Atwood SX
    Exp Dermatol; 2021 Mar; 30(3):358-366. PubMed ID: 33617094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.
    Kim AL; Back JH; Chaudhary SC; Zhu Y; Athar M; Bickers DR
    J Invest Dermatol; 2018 Aug; 138(8):1716-1725. PubMed ID: 29550418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas.
    Atwood SX; Li M; Lee A; Tang JY; Oro AE
    Nature; 2013 Feb; 494(7438):484-8. PubMed ID: 23446420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
    Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
    Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
    Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
    Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.
    Mirza AN; Fry MA; Urman NM; Atwood SX; Roffey J; Ott GR; Chen B; Lee A; Brown AS; Aasi SZ; Hollmig T; Ator MA; Dorsey BD; Ruggeri BR; Zificsak CA; Sirota M; Tang JY; Butte A; Epstein E; Sarin KY; Oro AE
    JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K Promotes Basal Cell Carcinoma Growth Through Kinase-Induced p21 Degradation.
    Chow RY; Jeon US; Levee TM; Kaur G; Cedeno DP; Doan LT; Atwood SX
    Front Oncol; 2021; 11():668247. PubMed ID: 34268113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Mammalian Target of Rapamycin Pathway Activation in Basal Cell Carcinoma as a New Therapeutic Approach.
    Chang ALS; Brown R; Li S; Betancourt N; Teng J
    Am J Dermatopathol; 2024 Sep; 46(9):588-592. PubMed ID: 38648034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patched-2 functions to limit Patched-1 deficient skin cancer growth.
    Veenstra VL; Dingjan I; Waasdorp C; Damhofer H; van der Wal AC; van Laarhoven HW; Medema JP; Bijlsma MF
    Cell Oncol (Dordr); 2018 Aug; 41(4):427-437. PubMed ID: 29869097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation.
    Uhmann A; Niemann H; Lammering B; Henkel C; Hess I; Nitzki F; Fritsch A; Prüfer N; Rosenberger A; Dullin C; Schraepler A; Reifenberger J; Schweyer S; Pietsch T; Strutz F; Schulz-Schaeffer W; Hahn H
    Mol Cancer Ther; 2011 Nov; 10(11):2179-88. PubMed ID: 21878656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
    Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG
    PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Approaches in Non-Melanoma Skin Cancers-A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC).
    Chmiel P; Kłosińska M; Forma A; Pelc Z; Gęca K; Skórzewska M
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
    Rahman MM; Hazan A; Selway JL; Herath DS; Harwood CA; Pirzado MS; Atkar R; Kelsell DP; Linton KJ; Philpott MP; Neill GW
    Cancer Res; 2018 May; 78(10):2577-2588. PubMed ID: 29463581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.
    Moutasim KA; Mellows T; Mellone M; Lopez MA; Tod J; Kiely PC; Sapienza K; Greco A; Neill GW; Violette S; Weinreb PH; Marshall JF; Ottensmeier CH; Sayan AE; Jenei V; Thomas GJ
    J Pathol; 2014 Jun; 233(2):196-208. PubMed ID: 24573955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer drugs and the regulation of Hedgehog genes GLI1 and PTCH1, a comparative study in nonmelanoma skin cancer cell lines.
    Olesen UH; Bojesen S; Gehl J; Haedersdal M
    Anticancer Drugs; 2017 Nov; 28(10):1106-1117. PubMed ID: 28799948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma.
    Kuonen F; Huskey NE; Shankar G; Jaju P; Whitson RJ; Rieger KE; Atwood SX; Sarin KY; Oro AE
    J Invest Dermatol; 2019 Jul; 139(7):1439-1448. PubMed ID: 30707899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog signaling in basal cell carcinoma.
    Otsuka A; Levesque MP; Dummer R; Kabashima K
    J Dermatol Sci; 2015 May; 78(2):95-100. PubMed ID: 25766766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog Pathway Alterations Downstream of Patched-1 Are Common in Infundibulocystic Basal Cell Carcinoma.
    Russell-Goldman E; MacConaill L; Hanna J
    Am J Dermatopathol; 2021 Apr; 43(4):266-272. PubMed ID: 32796174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.
    Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J
    Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
    Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
    Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.